Clinical Trials: Brain Cancer

California

Duarte; City of Hope
A Phase IIa Study of ADV-TK + Valacyclovir Gene Therapy in Combination with Standard Radiation Therapy for Malignant Gliomas

Duarte; City of Hope
A Phase Ib Study of ADV-TK + Valacyclovir Gene Therapy in Combination with Standard Radiation Therapy for Malignant Gliomas

Duarte; City of Hope[*]
A Phase I Study of the Combination of Radiation Therapy (RT), Arsenic Trioxide (ATO) and Temozolomide (TMZ) in Patients with Newly-Diagnosed Glioblastoma Multiforme (GBM)

Sacramento; Sutter Institute for Medical Research (SIMR)
Tissue Bank

New York

New York; Biomedical Research Alliance of New York
Primary Brain Cancer - Adults

Texas

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Primary Malignant Brain Tumor

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Glioblastoma Multiforme

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Neurofibroma And Schwannoma

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Mixed Glioma

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Oligodendroglioma

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Low Grade Astrocytoma

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 and AS2-1 in adult patients with Anaplastic Astrocytoma

Houston; S. R. Burzynski Clinic
A phase II study demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with rhabdoid tumor of the central nervous system by determining the proportion of patients who experience an objective tumor responses

Houston; S. R. Burzynski Clinic
A phase II study demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with low grade astrocytoma by determining the proportion of patients who experience an objective tumor responses

Houston; S. R. Burzynski Clinic
A phase II study demonstrate the anti-tumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with Primitive neuroectodermal tumors by determining the proportion of patients who experience an objective tumor responses.

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Ependymoma

Houston; S. R. Burzynski Clinic
A phase II study to demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of patients with brain stem glioma by determining the proportion of patients who experience an objective tumor response.

Houston; S. R. Burzynski Clinic
A phase II study to demonstrate the anti-tumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with brain tumors by determining the proportion of patients who experience an objective tumor response

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Children With Primary Malignant Brain Tumors

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Children With Visual Pathway Glioma

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Patients With Brain Tumors

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 and AS2-1 in Patients with Anaplastic Astrocytoma

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2 1 In Patients With Glioblastoma Multiforme

Houston; S. R. Burzynski Clinic
A phase II BT-6 study of Antyneoplastons A10 and AS2-1 Infusions in Children with High Grade Glioma

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Meningioma

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Infusions Private In Patients With Germ Cell Tumor Of The Brain

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Infusions Private In Patients With Choroid Plexus Neoplasm

Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Craniopharyngioma


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: October 6, 2008 at 3:47:39 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA